Drugs / Pangramin SLIT HDM mix
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01603056 | Oct 2009 → Feb 2012 | allergic rhinitis | ALK-Abelló A/S | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pangramin SLIT HDM mix | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01603056 ↗ |
| Known as | Pangramin SLIT | “Extensive clinical experience has been gained due to the widespread use of Pangramin® SLIT and other SLIT products as named patient products” NCT01603056 ↗ |